NCT03041428View on ClinicalTrials.gov

Ultra Protective Ventilation During Venoarterial Extracorporeal Membrane Oxygenation (UPV-ECMO)

NACompletedINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

February 1, 2017

Primary Completion Date

December 31, 2019

Study Completion Date

March 1, 2021

Conditions
Cardiogenic Pulmonary EdemaVentilator-Induced Lung InjuryExtracorporeal Circulation; Complications
Interventions
DEVICE

Ultraprotective ventilation

Adjusting ventilator parameters for 3 ml/kg of tidal volume in order to achieve the ultra protective strategy

Trial Locations (1)

33011

Hospital Universitario Central de Asturias (HUCA), Oviedo

All Listed Sponsors
lead

Fundación para la Investigación Biosanitaria del Principado de Asturias

OTHER

NCT03041428 - Ultra Protective Ventilation During Venoarterial Extracorporeal Membrane Oxygenation (UPV-ECMO) | Biotech Hunter | Biotech Hunter